A variety of neurological sequelae to mumps have been reported including meningitis, encephalitis, myelitis and rarely polyneuropathy.' By 1981 a total of ten cases fulfilling accepted diagnostic criteria for Guillain-Barre syndrome had been reported2
and half of these cases were associated with orchitis. We can find no subsequent reports of this association and would like to report a further case of Guillain-Barre syndrome following mumps parotitis and orchitis.
A 48 year old male was admitted on 9 December 1988 with progressive generalised muscle weakness. Three weeks earlier he had developed bilateral painful parotid swelling and within days this was followed by pain and swelling of the left testicle. Out of all 386 patients studied, 17 had MVP. One had atrial fibrillation and was excluded from the study. The mean (SD) age of the 16 remaining patients was 32 (9-2). Seven were male and nine female. Seven patients presented with TIA and four with RIND. The other five had established stroke. Only one had had previous ischaemic events and none of them was hypertensive or diabetic. ECG was normal in 13 patients, but one had an ischaemic pattern and two showed branch block. The non-invasive study of extracranial arteries was normal in all patients. Two had aortic valve prolapse and another had tricuspid valve prolapse in the echocardiographic study.
During a mean (SD) follow up period of 35 (16) months on treatment with antiplatelet drugs, only three patients had new ischaemic events: one had TIA, another RIND, and the third six TIAs. Such patients coincided with those who presented with multiple valvular prolapses.
The evaluation of our series suggest that the incidence of MVP is not so great in the group of young adults with ischaemic stroke as has been stated, especially not in the youngest patients. However, our data reinforce the existence of high risk groups in those patients with multiple valvular prolapse.
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